RecruitingNCT06079424
Risk Markers of Arterial Aging. The Paris Prospective Study III-2
Risk Markers of Arterial Aging and Subsequent Risk of Cardiovascular Diseases and Beyond. The Paris Prospective Study III-2
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment
7,500 participants
Start Date
Jun 20, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
Eligibility
Min Age: 60 YearsMax Age: 95 Years
Inclusion Criteria1
- Being enrolled in PPS3 and having signed an informed consent for PPS3-2
Exclusion Criteria3
- Institutionalized participants
- Participants under guardianship
- Participants under judicial safeguard measure
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERhigh-precision carotid echo-tracking
evaluation of vascular aging parameters and baroreflex sensitivity
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06079424
Related Trials
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
NCT065449541 location
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure
NCT067355991 location
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
NCT067356511 location
The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial Deformation
NCT073249022 locations
Natural History Study of CADASIL
NCT050724831 location